AJ

Anuj Jagdish Saxena

Active Director Director DIN 00751313
DIN 00751313 First appointment Oct 1989 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 10 active board seats
Past companies 4 historical roles
Total affiliations 14 Since Oct 1989
Shareholding value β€’β€’β€’β€’ Premium profile
Directorship timeline
First appointment 03 Oct 1989
Active appointments 12
Total timeline records 14

Anuj Jagdish Saxena (DIN 00751313) has 14 recorded board appointments in Indian companies, the first from October 1989, of which 12 are current. The chart and the list below show each company, the role held and the years of the appointment, as filed with the Ministry of Corporate Affairs.

Appointment history

Since 1989
Elder Bioleafage Healthcare Private Limited Director · 2025 – present
Current
Elder Prroject Limited Director · 2021 – present
Current
Ewf Pharmaceuticals Private Limited Director · 2020 – present
Current
Maverick Bioscope Private Limited Director · 2020 – present
Current
Apricot Capitals Private Limited Director · 2020 – present
Current
Anuj Saxena Entertainment Private Limited Director · 2020 – present
Current
Redle Pharmaceuticals Private Limited Director · 2020 – present
Current
Limelight Communications Private Limited Director · 2020 – present
Current
Elder Projects Limited Managing Director · 2005 – present
Current
Maverick Productions Private Limited Director · 2005 – present
Current
Elder Health Care Limited Managing Director · 2004 – present
Current
Akshaya Holdings Private Limited Director · 1989 – present
Current
Elder Pharmavitamins Private Limited Director · 2024 – 2025
Previous
Maveer Prints Private Limited Director · 2005 – 2019
Previous

Interactive timeline

Hover bars for tenure details
Loading chart...
Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available